Cargando…
Curcumin enhances the effectiveness of cisplatin by suppressing CD133(+) cancer stem cells in laryngeal carcinoma treatment
Chemoresistance is one of the major barriers to chemotherapeutic treatment and it has been established that CD133(+) cancer stem cells are responsible for drug resistance in laryngeal carcinoma. In the present study, curcumin and cisplatin were used as a combined treatment to induce the sensitivity...
Autores principales: | ZHANG, HEJIA, YU, TIANYU, WEN, LIANJI, WANG, HUI, FEI, DAN, JIN, CHUNSHUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820845/ https://www.ncbi.nlm.nih.gov/pubmed/24223665 http://dx.doi.org/10.3892/etm.2013.1297 |
Ejemplares similares
-
Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles
por: Wang, Ding, et al.
Publicado: (2020) -
Identification and characterization of CD133(+)CD44(+) cancer stem cells from human laryngeal squamous cell carcinoma cell lines
por: Wang, Jue, et al.
Publicado: (2017) -
Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma
por: Song, Yeonhwa, et al.
Publicado: (2020) -
CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro
por: BLANCAS-MOSQUEDA, MARISOL, et al.
Publicado: (2012) -
Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma
por: Yu, Lan, et al.
Publicado: (2014)